Differential Effects of Intra-accumbens and Systemic Amphetamine on Latent Inhibition Using an On-baseline, Within-subject Conditioned Suppression Paradigm
Overview
Authors
Affiliations
Latent inhibition (LI) is a phenomenon in which repeated, non-reinforced presentation of a stimulus retards subsequent conditioning to that stimulus. Several recent experiments have suggested that LI is abolished following acute, low doses of amphetamine given during pre-exposure and conditioning, and this effect has been attributed to amphetamine-induced changes in dopamine levels in the nucleus accumbens. Experiments 1 and 2 examined the effects of two doses of intra-accumbens d-amphetamine (10 micrograms/microliters and 3 micrograms/microliters) on LI in an on-baseline, within-subject conditioned suppression paradigm. There was no effect of either dose on LI, but a significant disinhibition of conditioned suppression resulted in a retardation of learning. In experiment 3 the effects of a low dose of systemic d-amphetamine (0.5 mg/kg) on latent inhibition were examined. The results replicated the abolition of LI found in previous studies, and demonstrated enhanced post-shock suppression in amphetamine-treated animals. These data provide no evidence for the involvement of the mesolimbic dopamine system in LI.
George D, Killcross S, Haddon J Oxf Open Neurosci. 2024; 2:kvad003.
PMID: 38596235 PMC: 10913818. DOI: 10.1093/oons/kvad003.
Navarro S, Alvarez R, Colomina M, Sanchez-Santed F, Flores P, Moreno M Schizophr Bull. 2016; 43(4):778-787.
PMID: 27872269 PMC: 5472118. DOI: 10.1093/schbul/sbw141.
Rethinking the emotional brain.
LeDoux J Neuron. 2012; 73(4):653-76.
PMID: 22365542 PMC: 3625946. DOI: 10.1016/j.neuron.2012.02.004.
Pre-exposure enhances recovery of conditioned responding after extinction.
Rosenberg H, Holmes N, Harris J, Westbrook R Learn Behav. 2011; 39(3):212-23.
PMID: 21327608 DOI: 10.3758/s13420-011-0019-5.
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.
Nelson A, Thur K, Marsden C, Cassaday H J Psychopharmacol. 2011; 25(12):1649-60.
PMID: 21262855 PMC: 3267554. DOI: 10.1177/0269881110389211.